Weight-Based Insulin Dosing Algorithm
For hospitalized non-critically ill patients with hyperglycemia, initiate basal-bolus insulin at 0.4-0.5 units/kg/day total daily dose (TDD), distributed as 50% basal and 50% prandial insulin divided before meals, with lower starting doses (0.2-0.3 units/kg/day) reserved for elderly patients (≥70 years), those with renal impairment (GFR <60), or poor oral intake. 1, 2
Initial Dosing Based on Clinical Severity
Mild-to-Moderate Hyperglycemia (BG 140-200 mg/dL)
- Start with 0.4 units/kg/day TDD 1
- Distribute as:
- 50% basal insulin (glargine or detemir once daily, or NPH twice daily)
- 50% prandial insulin (rapid-acting analog divided equally before three meals)
- Alternative: Basal-plus approach with 0.1-0.25 units/kg/day basal insulin alone plus correctional doses for patients with decreased oral intake 2
Severe Hyperglycemia (BG 201-400 mg/dL)
- Start with 0.5 units/kg/day TDD 1
- Same 50/50 distribution between basal and prandial
- For glucocorticoid-induced hyperglycemia: 0.5-0.6 units/kg/day with 40% basal and 60% prandial (or alternative 30% basal/70% prandial) 3
High-Risk Populations (Reduced Dosing)
- 0.2-0.3 units/kg/day for: 1, 2
- Age ≥70 years
- GFR <60 mL/min
- Poor or uncertain oral intake
- Risk factors for hypoglycemia
Adjusting for Pre-Hospital Insulin Use
Patients already on insulin at home:
- If home TDD <0.6 units/kg/day: Continue similar dose with 50/50 distribution 2
- If home TDD ≥0.6 units/kg/day: Reduce by 20% to prevent hypoglycemia from decreased oral intake 2
- For patients on basal-heavy regimens (basal ≥0.6-1.0 units/kg/day): Reduce basal by 10-20% and redistribute to prandial insulin 4
Special Circumstances: Glucocorticoid-Induced Hyperglycemia
When steroids are administered, add NPH insulin matched to steroid timing: 3
Prednisone/Methylprednisolone
- Start basal-bolus at 0.5 units/kg/day
- Add NPH at 0.1-0.4 units/kg based on prednisone dose increments (e.g., prednisone 10 mg = 0.1 units/kg NPH)
- Give NPH at same time as glucocorticoid dose
- Alternative: 0.5 units/mg prednisone equivalent as NPH
Dexamethasone
- Administer NPH twice daily instead of once (due to longer dexamethasone half-life) 3
- Or use long-acting basal insulin (glargine) with correctional doses
Critical Safety Thresholds
The 0.6 units/kg/day threshold is crucial: doses above this significantly increase hypoglycemia risk (OR 2.10-2.95) without proportional glycemic benefit 5. Research demonstrates that:
- Doses <0.6 units/kg/day: Relatively low hypoglycemia odds
- Doses 0.6-0.8 units/kg/day: 2.1-fold increased hypoglycemia risk
- Doses >0.8 units/kg/day: 3-fold increased hypoglycemia risk 5
Transitioning from IV Insulin Infusion
When discontinuing IV insulin infusion:
- Calculate TDD from average hourly infusion rate × 24 hours 2
- Example: 1.5 units/hour average = 36 units/day TDD
- Initiate weight-based basal insulin (0.2-0.25 units/kg) during the final 12 hours of IV infusion, not after 6
- This approach reduces rebound hyperglycemia at 24 hours post-infusion without increasing hypoglycemia 6
Distribution Formulas for Bolus Dosing
For patients requiring prandial insulin calculations:
- Insulin-to-carbohydrate ratio (ICR) = 300 ÷ TDD 7
- Correction factor (CF) = 1500 ÷ TDD 7
- Relationship: 100 ÷ basal dose = ICR = CF ÷ 4.5 7
Common Pitfalls to Avoid
- Never use sliding-scale insulin alone in patients with known diabetes—it causes unacceptable hyperglycemia (3-fold increased risk of BG >200 mg/dL) 1, 2
- Avoid premixed insulin (70/30) in hospitals—unacceptably high hypoglycemia rates 2
- Don't delay scheduled insulin for persistent hyperglycemia (≥2 readings ≥180 mg/dL in 24 hours on correctional insulin alone) 4
- Discontinue oral diabetes medications at admission—contraindications are common and delays achieving glycemic targets 1
Titration Strategy
- Adjust doses by 10-20% based on glucose patterns 1
- For hypoglycemia without clear cause: Reduce corresponding insulin dose by 10-20% 8
- Target glucose range: 100-180 mg/dL (5.6-10.0 mmol/L) 4
This weight-based approach with basal-bolus distribution provides superior glycemic control compared to sliding-scale insulin alone, with 4-6 times higher hypoglycemia risk that remains acceptable when doses stay below 0.6 units/kg/day 2, 5.